Javascript must be enabled to continue!
Predictors of VT recurrence in patients with VT inducibility at the end of radiofrequency ablation: Should we use VT non-inducibility as a routine endpoint?
View through CrossRef
Introduction: It has been reported that ventricular tachycardia (VT)
non-inducibility at the end of ablation is associated with less likely
VT recurrence. However, it is not clear whether we should use VT
non-inducibility as routine end point in VT ablation. The aim of this
study was to evaluate VT recurrence in patients in whom VT
non-inducibility could not be achieved at the end of the RF ablation and
the factors attributing to the VT recurrence. METHODS and RESULTS: We
analyzed 84 consecutive patients that underwent RF ablation, and 64
patients in whom VT non-inducibility could not be achieved were studied.
The primary endpoint was recurrence of any sustained VT during the
follow-up. During a median follow-up period of 1.4 years (IQR:0.3-2.0),
22 (34%) of the cases had VT recurrences. In the multivariate analysis
showed that an LVEF≥35% (HR:0.21; 95% CI:0.07- 0.54; P<0.01)
and successful identification and ablation of all clinical VT isthmuses
(HR:0.21; 95% CI:0.03- 0.72; P=0.01) were independent predictors of
fewer VT recurrences. RF ablation was associated with a 91.1% reduction
in VT episodes. CONCLUSION: Even if VT non-inducibility could not be
achieved, the patients with LVEF≥35% or in whom all clinical VT
isthmuses could successfully be identify and ablated might be prevented
from having VT recurrences. The validity of VT non-inducibility of any
VT should be evaluated by each patient’s background and the results of
the procedure.
Title: Predictors of VT recurrence in patients with VT inducibility at the end of radiofrequency ablation: Should we use VT non-inducibility as a routine endpoint?
Description:
Introduction: It has been reported that ventricular tachycardia (VT)
non-inducibility at the end of ablation is associated with less likely
VT recurrence.
However, it is not clear whether we should use VT
non-inducibility as routine end point in VT ablation.
The aim of this
study was to evaluate VT recurrence in patients in whom VT
non-inducibility could not be achieved at the end of the RF ablation and
the factors attributing to the VT recurrence.
METHODS and RESULTS: We
analyzed 84 consecutive patients that underwent RF ablation, and 64
patients in whom VT non-inducibility could not be achieved were studied.
The primary endpoint was recurrence of any sustained VT during the
follow-up.
During a median follow-up period of 1.
4 years (IQR:0.
3-2.
0),
22 (34%) of the cases had VT recurrences.
In the multivariate analysis
showed that an LVEF≥35% (HR:0.
21; 95% CI:0.
07- 0.
54; P<0.
01)
and successful identification and ablation of all clinical VT isthmuses
(HR:0.
21; 95% CI:0.
03- 0.
72; P=0.
01) were independent predictors of
fewer VT recurrences.
RF ablation was associated with a 91.
1% reduction
in VT episodes.
CONCLUSION: Even if VT non-inducibility could not be
achieved, the patients with LVEF≥35% or in whom all clinical VT
isthmuses could successfully be identify and ablated might be prevented
from having VT recurrences.
The validity of VT non-inducibility of any
VT should be evaluated by each patient’s background and the results of
the procedure.
Related Results
VT recurrence and predictors in patients with VT inducibility at the end of VT ablation
VT recurrence and predictors in patients with VT inducibility at the end of VT ablation
Abstract
Background
A successful Radiofrequency (RF) ablation of ventricular tachycardia (VT) can prevent VT recurrence. It has ...
Microwave Ablation with or Without Chemotherapy in Management of Non-Small Cell Lung Cancer: A Systematic Review
Microwave Ablation with or Without Chemotherapy in Management of Non-Small Cell Lung Cancer: A Systematic Review
Abstract
Introduction
Microwave ablation (MWA) has emerged as a minimally invasive treatment for patients with inoperable non-small cell lung cancer (NSCLC). However, whether it i...
Management of Lower Limb Varicose Veins Using Endovenous Laser Ablation, Micro-Phlebectomy, and Sclerotherapy Using Multimodal Analgesia
Management of Lower Limb Varicose Veins Using Endovenous Laser Ablation, Micro-Phlebectomy, and Sclerotherapy Using Multimodal Analgesia
Abstract
Introduction
Previously, the conventional surgical procedure of high-ligation and saphenous stripping was commonly used to treat varicose veins (VVs). However, contemporar...
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Abstarct
Introduction
Isolated brain hydatid disease (BHD) is an extremely rare form of echinococcosis. A prompt and timely diagnosis is a crucial step in disease management. This ...
The advantage of mini electrode-equipped catheter for the radiofrequency ablation of paroxysmal supraventricular tachycardia
The advantage of mini electrode-equipped catheter for the radiofrequency ablation of paroxysmal supraventricular tachycardia
Introduction: Novel ablation catheters equipped with
mini-electrodes (ME) offer high resolution mapping for target tissue.
This study aimed to evaluate the mapping performance and ...
Long term success of cavotricuspid isthmus ablation guided by the ablation index: results of the FLAI registry
Long term success of cavotricuspid isthmus ablation guided by the ablation index: results of the FLAI registry
Abstract
Funding Acknowledgements
Type of funding sources: None.
Introduction
...
Ablation Performance of C/SiC-ZrC Composites
Ablation Performance of C/SiC-ZrC Composites
Abstract
To reveal the ablation performance of C/SiC-ZrC composites under different ablation methods, C/SiC-ZrC composites were prepared by chemical vapor deposition and pr...
Predictors of Atrial Fibrillation Recurrence after Ablation
Predictors of Atrial Fibrillation Recurrence after Ablation
Various treatment methods have been used for atrial fibrillation (AF), which has long been a cause of cerebral infarction and heart failure. Antiarrhythmic drug, the first develope...

